SRNE have been volatile for awhile but one of the best player in the COVID time , analyst targeting high price 25$ to 30$ and currently undervalue considering the revenue from the test kit alone and may be going to target price with further development in the pipeline products and more development in the treatment and vaccine
Trade closed: target reached